European Medicines Agency invests in AstraZeneca vaccine for blood vessels
The European Medicines Agency (EMA) declares that it is investigating a possible angle of the AstraZeneca antiviral vaccine with a habitual problem of vascular vesicles, as well as a possible relat…
